Baricitinib

A Baricitinib is a Janus kinase inhibitor.

• Context:
  • It can be a Disease Treatment (for rheumatoid arthritis).
  • …
• Counter-Example(s):
  • a TNF Inhibitor.
• See: Oral Administration, CYP3A4, JAK1, JAK2.

---

---

References

2020

• (Wikipedia, 2020) ⇒ https://en.wikipedia.org/wiki/baricitinib Retrieved:2020-3-7.
  • Baricitinib (trade name Olumiant) is a drug for the treatment of rheumatoid arthritis (RA), being developed by Incyte and Eli Lilly. It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2. The drug is approved in Europe.

---